PANDAA Yellow Fever

A universal molecular diagnostic to detect all Yellow fever virus genotypes while distinguishing infections caused by wild-type virus from adverse events arising from immunization with the Yellow fever live, attenuated vaccine.

For Research Use Only. This test has not been cleared or approved by the U.S. Food and Drug Administration (FDA). PANDAA® is a registered trademark of Aldatu Biosciences. 

Overview

Currently under development. Questions? Email sales@aldatubio.com

 

  • The only assay capable of detecting all genotypes of wild-type and vaccine strains of Yellow fever virus.
  • Fast – delivers accurate results from RNA in 1 hour
  • Platform-agnostic – compatible with most sample prep and qPCR platforms.
Key Features

Technical Specifications

Analytical Sensitivity

Kit Contents

Ordering

Get in touch: ebola@aldatubio.com

Get in touch

Documentation

Instructions for Use

  • Coming soon. 

Other Documentation

  • Safety data sheets (link)
  • Certificate of analysis (link)

Real-Time PCR Templates

For Research Use Only. This test has not been cleared or approved by the U.S. Food and Drug Administration (FDA).

This product is covered by one or more patents, trademarks and / or copyrights owned or controlled by Aldatu Biosciences, Inc. PANDAA® is a registered trademark of Aldatu Biosciences, Inc. PANDAA primer and probe designs are proprietary to Aldatu Biosciences.

Order

Select your country from the dropdown to ensure that the correct pricing is shown for low- and middle-income countries.

$-

Documentation

Instructions for Use

  • Coming soon. 

Other Documentation

  • Safety data sheets (link)
  • Certificate of analysis (link)

Real-Time PCR Templates

Kit Contents